Table 2 Baseline Echocardiogram Information of HF Population Stratified by LVEF

 LV enlargement (LVEDD>55 mm(Male), 50 mm(Female)), n(%)

188 (89.1%)^#

136 (67.7%)*^#

96 (28.0%)*

< 0.001

 LV end-diastolic diameter (mm)

61 (48–68)

56 (46–61)

47 (41–57)

 LV end-diastolic volume (ml)

176 (123–189)

146 (117–161)

99 (90–123)

 LA enlargement (LAD>39 mm), n(%)

176 (83.4%)^#

125 (62.2%)*^#

177 (51.6%)*

< 0.001

 LA diameters

42 (36–47)

41 (34–46)

39 (32–45)

 RV enlargement (RVEDD>25 mm), n(%)

65 (30.8%)^#

22 (10.9%)*

39 (11.4%)*

< 0.001

 RV systolic dysfunction (TAPSE< 16 mm), n(%)

27 (12.8%)^#

9 (4.5%)*

20 (5.8%)*

0.002

 RA enlargement (RAD>40 mm), n(%)

83 (39.3%)^#

48 (23.9%)*

82 (23.9%)*

< 0.001

 LV diastolic dysfunction (E/A ratio < 0.8), n(%)

19 (9.0%)^#

28 (13.9%)^#

78 (22.7%)*

< 0.001

 Pulmonary hypertension (PASP>40 mmHg), n(%)

60 (28.4%)^#

38 (18.9%)

66 (19.2%)*

0.021

 Valve abnormity, n(%)

112 (53.1%)^#

76 (37.8%)*

123 (36.9%)*

< 0.001